These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26147909)

  • 1. Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management.
    Saunte DM; Mrowietz U; Puig L; Zachariae C
    Br J Dermatol; 2017 Jul; 177(1):47-62. PubMed ID: 27580411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry.
    Zweegers J; Groenewoud JMM; van den Reek JMPA; Otero ME; van de Kerkhof PCM; Driessen RJB; van Lümig PPM; Njoo MD; Ossenkoppele PM; Mommers JM; Koetsier MIA; Arnold WP; Andriessen MPM; Kuijpers ALA; Berends MAM; Kievit W; de Jong EMGJ
    Br J Dermatol; 2017 Apr; 176(4):1001-1009. PubMed ID: 27579864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic Review Characterizing Psoriatic Arthritis Onset and Exacerbation in Patients Receiving Biologic Therapy.
    Sachdeva M; Abduelmula A; Mufti A; Georgakopoulos JR; Lytvyn Y; Yeung J
    J Cutan Med Surg; 2022; 26(4):414-419. PubMed ID: 35317662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study.
    Iannone LF; Bennardo L; Palleria C; Roberti R; De Sarro C; Naturale MD; Dastoli S; Donato L; Manti A; Valenti G; D'Amico D; D'Attola S; De Francesco AE; Bosco V; Donato Di Paola E; Nisticò SP; Citraro R; Russo E; De Sarro G
    PLoS One; 2020; 15(11):e0241575. PubMed ID: 33141869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Meningococcal and HSV-2 Meningitis in a Patient Being Treated with Ustekinumab for Pityriasis Rubra Pilaris.
    Kalogeropoulos CI; Papathanasiou KA; Tsagkaraki I; Giannopoulos G; Bamias A; Boutati EI
    Eur J Case Rep Intern Med; 2020; 7(8):001615. PubMed ID: 32789127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events.
    Subedi S; Gong Y; Chen Y; Shi Y
    Drug Des Devel Ther; 2019; 13():2491-2502. PubMed ID: 31413544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Biologic Therapies in Dermatology.
    Fathi R; Armstrong AW
    Med Clin North Am; 2015 Nov; 99(6):1183-94. PubMed ID: 26476247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience With Anti-TNF-α Biologic Agents in Succession in Patients With Crohn's Disease: A Retrospective Analysis of a Single Center.
    Ferges W; Rampertab SD; Shafqet M; Salimi Q; You G; Yousefzadeh E; Cheng JQ; Das KM
    J Clin Gastroenterol; 2016 Apr; 50(4):326-30. PubMed ID: 25984976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation.
    Maloney NJ; Hisaw LD; Worswick S
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 29034547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Reactions to Biologics in Psoriasis.
    Lockwood SJ; Prens LM; Kimball AB
    Curr Probl Dermatol; 2018; 53():1-14. PubMed ID: 29131033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications and adverse reactions in the use of newer biologic agents.
    Callen JP
    Semin Cutan Med Surg; 2007 Mar; 26(1):6-14. PubMed ID: 17349557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologics in dermatology: adverse effects.
    Sehgal VN; Pandhi D; Khurana A
    Int J Dermatol; 2015 Dec; 54(12):1442-60. PubMed ID: 26147909
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.